Trial Profile
A Randomized Comparison of Immediate Versus Delayed Treatment With Intravitreal Injections of ISIS 2922 in Patients With Peripheral Cytomegalovirus (CMV) Retinitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jan 2016
Price :
$35
*
At a glance
- Drugs Fomivirsen (Primary)
- Indications Cytomegalovirus retinitis
- Focus Therapeutic Use
- Sponsors Ionis Pharmaceuticals
- 08 Jan 2016 New trial record